Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Sunshine Biopharma Inc. - Common stock (NQ:SBFM)

1.370 -0.040 (-2.84%)
Streaming Delayed Price Updated: 3:59 PM EST, Jan 8, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Sunshine Biopharma Inc. - Common stock

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
News headline image
Mid-Morning Market Update: Markets Edge Lower; US Wholesale Inventories Rise 2.5% In February ↗
U.S. stocks traded mostly lower this morning, with the Nasdaq Composite dropping 100 points on Friday. 
Via Benzinga
News headline image
Benzinga's Daily Brief On Trending Tickers For April 8, 2022: SoFi, Tesla, Taiwan Semiconductors And More ↗
Benzinga’s “Daily Brief On Trending Tickers” highlights top-searched tickers from around the web and uses the Benzinga Pro platform to highlight recent news... 
Via Benzinga
News headline image
Why Sunshine Biopharma Stock Is Falling Today ↗
Sunshine Biopharma Inc (NASDAQ: SBFM) shares are trading lower Friday morning after the company announced a common stock offering. Sunshine Biopharma plans to offer... 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗
Good morning, trader! Get ready for another busy day of trading with our breakdown of the biggest pre-market stock movers for Friday! 
Via InvestorPlace
News headline image
16 Stocks Moving in Friday's Pre-Market Session ↗
Gainers Biofrontera Inc. (NASDAQ: BFRI) rose 34.5% to $5.44 in pre-market trading. ENDRA Life Sciences Inc. (NASDAQ: NDRA) rose 31.9% to $0.5891 in pre-market trading after... 
Via Benzinga
News headline image
53 Biggest Movers From Yesterday ↗
Gainers MedAvail Holdings, Inc. (NASDAQ: MDVL) shares surged 64.4% to close at $1.41 on Thursday. Ally Bridge Group reported a purchase of 21.176 million shares of MedAvail... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
Gainers Trevi Therapeutics (NASDAQ:TRVI) stock rose 45.8% to $2.77 during Thursday's regular session. Trevi Therapeutics's stock is trading at a volume of 15.2... 
Via Benzinga
News headline image
Stocks That Hit 52-Week Highs On Thursday ↗
On Thursday, 75 stocks made new 52-week highs. Interesting Highlights From Today's 52-Week Highs: The largest company by market cap to hit a new 52-week high... 
Via Benzinga
News headline image
38 Stocks Moving In Thursday's Mid-Day Session ↗
Gainers MedAvail Holdings, Inc. (NASDAQ: MDVL) jumped 57.6% to $1.3515. Ally Bridge Group reported a purchase of 21.176 million shares of MedAvail Holdings for an average price... 
Via Benzinga
News headline image
Benzinga's Daily Brief On Trending Tickers For April 7, 2022: SDPR S&P 500, Houghton Mifflin, Sunshine Biopharma And More ↗
Benzinga’s “Daily Brief On Trending Tickers” highlights top-searched tickers from around the web and uses the Benzinga Pro platform to highlight recent news... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
Gainers IMAC Holdings (NASDAQ:IMAC) shares increased by 60.0% to $1.6 during Thursday's pre-market session. The market value of their outstanding shares is at $41.9 million. 
Via Benzinga
News headline image
51 Biggest Movers From Yesterday ↗
Gainers Advent Technologies Holdings, Inc. (NASDAQ: ADN) shares climbed 79.7% to close at $3.63 on Wednesday. Advent Technologies and Hyundai Motor Company entered into... 
Via Benzinga
News headline image
Mid-Afternoon Market Update: Crude Oil Down 5%; Celsion Shares Plummet ↗
U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping 150 points on Wednesday. 
Via Benzinga
News headline image
What's Going On With Sunshine Biopharma Stock Today? ↗
Sunshine Biopharma Inc (NASDAQ: SBFM) is trading higher Wednesday on continued momentum after the company on Tuesday announced that two of its designed mRNA molecules are effective at destroying cancer... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
Gainers Sunshine Biopharma (NASDAQ:SBFM) shares rose 32.4% to $7.43 during Wednesday's regular session. Sunshine Biopharma's stock is trading at a volume of 46.8... 
Via Benzinga
News headline image
40 Stocks Moving In Wednesday's Mid-Day Session ↗
Gainers Advent Technologies Holdings, Inc. (NASDAQ: ADN) shares jumped 77.7% to $3.5950. Advent Technologies and Hyundai Motor Company entered into technology assessment, sales... 
Via Benzinga
News headline image
Sunshine Biopharma Sees Potential Multi-Billion Dollar Global Market Opportunity As Research Findings Reveal Effectiveness Against Multidrug-Resistant Cancer Cells ↗
Photo by Angiola Harry on Unsplash This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. 
Via Benzinga
News headline image
21 Stocks Moving in Wednesday's Pre-Market Session ↗
Gainers Dakota Gold (NYSE: DC) shares rose 97.1% to $13.60 in pre-market trading. The company’s stock was uplisted to NYSE American on Tuesday. BigBear.ai Holdings,... 
Via Benzinga
News headline image
51 Biggest Movers From Yesterday ↗
Gainers Sunshine Biopharma, Inc. (NASDAQ: SBFM) shares surged 148.2% to close at $5.61 on Tuesday after the company announced that two of its designed mRNA molecules are... 
Via Benzinga
News headline image
Mid-Afternoon Market Update: Dow Falls 150 Points; Cognyte Software Shares Drop ↗
U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping more than 150 points on Tuesday. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
Gainers Sunshine Biopharma (NASDAQ:SBFM) shares rose 141.5% to $5.46 during Tuesday's regular session. Trading volume for this security as of 13:30 EST is 114.7... 
Via Benzinga
News headline image
Sunshine Biopharma Stock Triples on Positive mRNA Cancer Treatment Results ↗
SBFM stock tripled to $6.53 on Tuesday after revealing that two of its newly designed mRNA molecules are effective in destroying cancer cells. 
Via InvestorPlace
News headline image
Mid-Day Market Update: Dow Dips Over 100 Points; Sunshine Biopharma Shares Surge ↗
U.S. stocks traded lower midway through trading, with the Dow Jones dropping more than 100 points on Tuesday. 
Via Benzinga
News headline image
30 Stocks Moving In Tuesday's Mid-Day Session ↗
Gainers Sunshine Biopharma, Inc. (NASDAQ: SBFM) shares jumped 139% to $5.40 after the company announced that two of its designed mRNA molecules are effective at destroying... 
Via Benzinga
News headline image
Dear NIO Stock Fans, Pay Attention to This HUGE Catalyst ↗
Nio (NIO) stock may not be doing so hot on Tuesday but reports of a major catalyst could turn that around in the near future. 
Via InvestorPlace
News headline image
Why Is Sunshine Biopharma (SBFM) Stock Up Today? ↗
Sunshine Biopharma (SBFM) stock is shining brighter on Tuesday after revealing the effects its mRNA molecules have against cancer. 
Via InvestorPlace
News headline image
Mid-Morning Market Update: Markets Mixed; ISM Services PMI Rises To 58.3 In March ↗
U.S. stocks traded mixed this morning, with the Nasdaq Composite dropping around 150 points on Tuesday. 
Via Benzinga
News headline image
Sunshine Biopharma Shares Are Soaring: Here's Why ↗
Sunshine Biopharma Inc (NASDAQ: SBFM) shares are trading significantly higher Tuesday after the company announced that two of its designed mRNA molecules are effective at... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
Gainers Sunshine Biopharma (NASDAQ:SBFM) shares moved upwards by 163.3% to $5.95 during Tuesday's pre-market session. The market value of their outstanding shares is... 
Via Benzinga
News headline image
EXCLUSIVE: Sunshine Biopharma's Newly Designed mRNA Molecules Effective Against Multidrug Resistant Cancer Cells ↗
Oncology and antiviral drugs focused Sunshine Biopharma Inc (NASDAQ: SBFM) has said that two of its newly designed mRNA molecules can effectively destroy cancer cells grown in culture.  
Via Benzinga
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.